flufenamic acid has been researched along with gamma-aminobutyric acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Fernández, M; Lao-Peregrín, C; Martín, ED | 1 |
| Frazier, CJ; Hofmann, ME | 1 |
| Lee, CR; Zhou, FM | 1 |
1 review(s) available for flufenamic acid and gamma-aminobutyric acid
| Article | Year |
|---|---|
Intrinsic and integrative properties of substantia nigra pars reticulata neurons.
Topics: Action Potentials; Animals; Flufenamic Acid; gamma-Aminobutyric Acid; Nerve Net; Neurons; Substantia Nigra; Synapses; Synaptic Transmission; TRPC Cation Channels | 2011 |
4 other study(ies) available for flufenamic acid and gamma-aminobutyric acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Epilepsy; Excitatory Postsynaptic Potentials; Flufenamic Acid; gamma-Aminobutyric Acid; Hippocampus; Inhibitory Postsynaptic Potentials; Neural Inhibition; Neurons; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2010 |
Muscarinic receptor activation modulates the excitability of hilar mossy cells through the induction of an afterdepolarization.
Topics: Animals; Calcium; Cannabinoid Receptor Modulators; Central Nervous System Agents; Dentate Gyrus; Flufenamic Acid; gamma-Aminobutyric Acid; In Vitro Techniques; Ion Channels; Male; Membrane Potentials; Mossy Fibers, Hippocampal; Muscarine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Sodium Channels; Synaptic Transmission | 2010 |